Dylan Beynon

Dylan Beynon, founder of Mindbloom and a pioneer in ketamine-assisted therapy, shares his journey from a challenging childhood marked by mental illness to launching a successful startup. He discusses the transformative power of ketamine and emphasizes the importance of preparation and integration in therapy. Dylan highlights how music enhances the healing process and reveals personal stories that shaped his optimistic outlook on life. He also addresses the media's scrutiny of his work and advocates for broader access to psychedelic treatments in tackling the mental health crisis.

Dylan Beynon, CEO and Founder of Mindbloom, shares his journey into psychedelic medicine sparked by personal loss. He discusses the transformative impact of at-home ketamine therapy, emphasizing its accessibility and success in aiding over 654,000 people. The conversation critiques the influence of Big Pharma, showcases innovative treatment approaches, and highlights Mindbloom's integration of technology for improved client experiences. Beynon also explores the future potential of MDMA therapy and the ongoing challenges in making these treatments widely accepted.

Dylan Beynon, CEO of Mindbloom, talks about starting the company and the impact of Ketamine and MDMA therapy. They discuss pricing, the largest clinical study, and Dylan's personal opinion on the therapies. They also touch on Vipassana Meditation and where to find more information about Mindbloom.